Back
ImmunityBio, Inc. Stock Price Chart
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now
Buy
62
IBRX
ImmunityBio, Inc.
Last Price:
$5.92
Seasonality Move:
-18.45%
7 Day Trial
ALL ACCESS PASS
$
7
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IBRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ImmunityBio, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.38 | Sell |
| 20-day SMA: | 4.02 | Buy |
| 50-day SMA: | 2.91 | Buy |
| 200-day SMA: | 2.66 | Buy |
| 8-day EMA: | 3.9 | Buy |
| 20-day EMA: | 2.04 | Buy |
| 50-day EMA: | 0.91 | Buy |
| 200-day EMA: | 0.24 | Buy |
ImmunityBio, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.37 | Buy |
| Relative Strength Index (14 RSI): | 72.25 | Buy |
| Chaikin Money Flow: | 22529896 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ImmunityBio, Inc. Technical Analysis
| Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 14 | 15 | 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ImmunityBio, Inc. Stock
Is ImmunityBio, Inc. Stock a Buy?
-
ImmunityBio, Inc. share price is 6.15 while IBRX 8-day simple moving average is 6.38, which is a Sell signal.
-
The stock price of IBRX is 6.15 while ImmunityBio, Inc. 20-day SMA is 4.02, which makes it a Buy.
-
ImmunityBio, Inc. 50-day simple moving average is 2.91 while IBRX share price is 6.15, making it a Buy technically.
-
IBRX stock price is 6.15 and ImmunityBio, Inc. 200-day simple moving average is 2.66, creating a Buy signal.
IBRX Technical Analysis vs Fundamental Analysis
Buy
62
ImmunityBio, Inc. (IBRX)
is a Buy
Is ImmunityBio, Inc. a Buy or a Sell?
-
ImmunityBio, Inc. stock is rated a BuyThe current ImmunityBio, Inc. [IBRX] share price is $6.15. The Score for IBRX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
ImmunityBio, Inc. Stock Info
Market Cap:
6.1B
Price in USD:
6.15
Share Volume:
35.3M
ImmunityBio, Inc. 52-Week Range
52-Week High:
8.28
52-Week Low:
1.83
Buy
62
ImmunityBio, Inc. (IBRX)
is a Buy
ImmunityBio, Inc. Share Price Forecast
-
What is the ImmunityBio, Inc. stock price today?The ImmunityBio, Inc. stock price is 6.15 USD today.
-
Will IBRX stock go up or go down?ImmunityBio, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is ImmunityBio, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ImmunityBio, Inc. is not overvalued.
Is ImmunityBio, Inc. Stock a Buy?
-
ImmunityBio, Inc. share price is 6.15 while IBRX 8-day exponential moving average is 3.90, which is a Buy signal.
-
The stock price of IBRX is 6.15 while ImmunityBio, Inc. 20-day EMA is 2.04, which makes it a Buy.
-
ImmunityBio, Inc. 50-day exponential moving average is 0.91 while IBRX share price is 6.15, making it a Buy technically.
-
IBRX stock price is 6.15 and ImmunityBio, Inc. 200-day simple moving average is 0.24, creating a Buy signal.
Fundamental Analysis of ImmunityBio, Inc.
Is ImmunityBio, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.27 per share.
Technical Analysis of ImmunityBio, Inc.
Should I short ImmunityBio, Inc. stock?
-
IBRX Moving Average Covergence Divergence (MACD) indicator is 1.37, suggesting ImmunityBio, Inc. is a Buy
-
ImmunityBio, Inc. Relative Strength Index (RSI) is 72.25, which suggest ImmunityBio, Inc. is overbought
-
The Bollinger Bands (25) for ImmunityBio, Inc. is ( - ), which suggest ImmunityBio, Inc. is a Buy
-
The Bollinger Bands (100) for ImmunityBio, Inc. is ( - ), which suggest ImmunityBio, Inc. is a Buy
* ImmunityBio, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.